Cargando…

Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey

BACKGROUND: Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems. AIM: To define the awareness and experiences of the clinicians on PV and adverse drug reactions (ADRs) in Turkey. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydin, Ozlem Celik, Aydin, Sonay, Guney, Hakkı Zafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424053/
https://www.ncbi.nlm.nih.gov/pubmed/37583988
http://dx.doi.org/10.12998/wjcc.v11.i20.4865
_version_ 1785089589168308224
author Aydin, Ozlem Celik
Aydin, Sonay
Guney, Hakkı Zafer
author_facet Aydin, Ozlem Celik
Aydin, Sonay
Guney, Hakkı Zafer
author_sort Aydin, Ozlem Celik
collection PubMed
description BACKGROUND: Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems. AIM: To define the awareness and experiences of the clinicians on PV and adverse drug reactions (ADRs) in Turkey. METHODS: The study was cross-sectional and analytical. Data were obtained through a questionnaire. The questionnaire was sent via e-mail. The survey was sent to 2030 physicians and 670 participated. RESULTS: The most appropriate definition of PV was correctly defined by 53.9% of the participants. The most important goal of PV was correctly defined by 54.9% of the participants, and 27.3% of the participants were aware of the Turkish Pharmacovigilance Center. Nonsurgical physicians had better PV knowledge than surgical physicians. A total of 80.9% of the physicians who encountered ADRs, filled in the ADR notification form, and 8.8% received training on how to fill in the form. PV knowledge of the clinicians was not sufficient. Although half of the physicians encountered ADRs, the rates of seeing and filling in the ADR form were low. CONCLUSION: Few of the physicians followed the current information about PV. The results provide more comprehensive data on PV practices and ADR reporting at a national level.
format Online
Article
Text
id pubmed-10424053
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-104240532023-08-15 Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey Aydin, Ozlem Celik Aydin, Sonay Guney, Hakkı Zafer World J Clin Cases Prospective Study BACKGROUND: Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems. AIM: To define the awareness and experiences of the clinicians on PV and adverse drug reactions (ADRs) in Turkey. METHODS: The study was cross-sectional and analytical. Data were obtained through a questionnaire. The questionnaire was sent via e-mail. The survey was sent to 2030 physicians and 670 participated. RESULTS: The most appropriate definition of PV was correctly defined by 53.9% of the participants. The most important goal of PV was correctly defined by 54.9% of the participants, and 27.3% of the participants were aware of the Turkish Pharmacovigilance Center. Nonsurgical physicians had better PV knowledge than surgical physicians. A total of 80.9% of the physicians who encountered ADRs, filled in the ADR notification form, and 8.8% received training on how to fill in the form. PV knowledge of the clinicians was not sufficient. Although half of the physicians encountered ADRs, the rates of seeing and filling in the ADR form were low. CONCLUSION: Few of the physicians followed the current information about PV. The results provide more comprehensive data on PV practices and ADR reporting at a national level. Baishideng Publishing Group Inc 2023-07-16 2023-07-16 /pmc/articles/PMC10424053/ /pubmed/37583988 http://dx.doi.org/10.12998/wjcc.v11.i20.4865 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Prospective Study
Aydin, Ozlem Celik
Aydin, Sonay
Guney, Hakkı Zafer
Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title_full Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title_fullStr Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title_full_unstemmed Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title_short Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
title_sort defining the awareness and attitude of the clinicians through pharmacovigilance in turkey
topic Prospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424053/
https://www.ncbi.nlm.nih.gov/pubmed/37583988
http://dx.doi.org/10.12998/wjcc.v11.i20.4865
work_keys_str_mv AT aydinozlemcelik definingtheawarenessandattitudeofthecliniciansthroughpharmacovigilanceinturkey
AT aydinsonay definingtheawarenessandattitudeofthecliniciansthroughpharmacovigilanceinturkey
AT guneyhakkızafer definingtheawarenessandattitudeofthecliniciansthroughpharmacovigilanceinturkey